Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 12 February 2027
- Last conf. stmt
- 29 January 2026
N4 Pharma UK Limited
- Incorporated
- 5 February 2014 (12 years)
- Previously known as
- N4 Pharma Limited (until 2 May 2017)This list may be incomplete. See all names on Companies House
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Owned by
- Accounts type
- Total exemption full
- Region
- Greater London
- Address
- 2 Portman StreetLondonW1H 6DU
Officers
Not loaded yet. See them on Companies House
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Public Limited Company
Reg. no. 01435584
Former controllers (2)
2 May 2017
Ceased Onzima Ventures PLC — Owns 75–100% of shares
12 April 2017
Ceased Nigel James Theobald — Owns 50–75% of shares
Group structure 4 companies
Ownership group derived from the Companies House PSC register
N4 Pharma UK Limited This company Owns 75–100% of shares
Nanogenics Limited Owns 50–75% of shares
Thalia Therapeutics UK Ltd Owns 75–100% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 17 April 2026 | Change of details for a person with significant control | |||
| 1 April 2026 | Registered office address changed | |||
| 17 March 2026 | Change of details for a person with significant control | |||
| 25 February 2026 | Appointment of a director | |||
| 24 February 2026 | Termination of appointment of a director |
Some other companies at this address
Other companies in this industry
Weybridge
Stevenage
Reading
Didcot
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →